Diabetics could be at risk with new 12-month prescriptions
Twelve-month prescriptions could put diabetics and other patients with long-term conditions at serious risk, warn GPs and specialists.
Twelve-month prescriptions could put diabetics and other patients with long-term conditions at serious risk, warn GPs and specialists.
A surprise Budget announcement about prescriptions has left one pharmacist perplexed.
Kiwis will soon be able to get 12-month prescriptions for medicines, Health Minister Simeon Brown and Associate Health Minister David Seymour revealed as part of today’s Budget.
Wait times for urgent, non-urgent and surveillance colonoscopies all progressively worsened last year as Health New Zealand failed to meet demand.
New Zealand’s pharmaceutical sector is cautiously optimistic over the industry being granted an exemption from US President Donald Trump’s tariffs.
The legislation will give the health minister the power to approve, reject or transfer medication applications
A popular weight-loss drug used by celebrities overseas has been approved by New Zealand’s medicine regulatory body, with its producer hoping to make it accessible “as soon as possible”.
The Medical Council is expected to release new guidelines for the use of artificial intelligence before the end of the year, according to board member Stephen Child.
Thousands of New Zealanders living with type 1 diabetes face a frustrating wait for potentially life-changing technology, despite a recent announcement from Pharmac that continuous glucose monitors (CGMs) and insulin pumps are now fully funded.
Some patients and advocacy groups see Pharmac as "slow to respond", "highly defensive" and "lacking respect" for them, according to an independent report released by the drug-funding agency today.
HEALTH SERVICES AND SYSTEMS
EQUITY
Exploring the impacts of the health system on minorities within the population, notably including Māori, Pacifica, Asians and LGBTQI.
DRUGS, DEVICE AND DIAGNOSTICS
PUBLIC HEALTH
DIGITAL HEALTH
TE TIRITI